{"name": "Crystax Pharmaceuticals",
 "permalink": "crystax-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/crystax-pharmaceuticals",
 "homepage_url": "http://www.crystax.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@crystax.com",
 "phone_number": "34-935151313",
 "description": "",
 "created_at": "Mon Sep 06 05:47:43 UTC 2010",
 "updated_at": "Mon Sep 06 06:02:43 UTC 2010",
 "overview": "\u003Cp\u003ECrystax Pharmaceuticals is a leading structure-based drug discovery company. They identify and develop new lead compounds by a combination of structural and biophysical techniques that accelerate the process of drug discovery and bring higher quality molecules to the market. Core areas of expertise are: X-ray Crystallography, NMR, Fragment Screening and Hit Optimization by biophysical analysis and computational chemistry.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       40],
      "assets/images/resized/0010/0654/100654v1-max-150x150.jpg"],
     [[246,
       67],
      "assets/images/resized/0010/0654/100654v1-max-250x250.jpg"],
     [[246,
       67],
      "assets/images/resized/0010/0654/100654v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.crystax.com/company/events/events_3.php",
    "source_description": "Crystax Pharmaceuticals closes financing round",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2005,
    "funded_month": 9,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Najeti Capital",
         "permalink": "najeti-capital",
         "image":
          {"available_sizes":
            [[[150,
               40],
              "assets/images/resized/0010/0661/100661v1-max-150x150.jpg"],
             [[240,
               65],
              "assets/images/resized/0010/0661/100661v1-max-250x250.jpg"],
             [[240,
               65],
              "assets/images/resized/0010/0661/100661v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Invertec",
         "permalink": "invertec",
         "image":
          {"available_sizes":
            [[[150,
               56],
              "assets/images/resized/0006/7431/67431v1-max-150x150.png"],
             [[250,
               94],
              "assets/images/resized/0006/7431/67431v1-max-250x250.png"],
             [[260,
               98],
              "assets/images/resized/0006/7431/67431v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Barcelona Science Park",
    "address2": "Josep Samitier 1-5",
    "zip_code": "E-08028",
    "city": "Barcelona",
    "state_code": null,
    "country_code": "ESP",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[142,
        150],
       "assets/images/resized/0010/0655/100655v1-max-150x150.jpg"],
      [[236,
        250],
       "assets/images/resized/0010/0655/100655v1-max-250x250.jpg"],
      [[426,
        450],
       "assets/images/resized/0010/0655/100655v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}